These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29679339)

  • 41. Tumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer.
    Reimer T; Koczan D; Müller H; Friese K; Thiesen HJ; Gerber B
    Breast Cancer Res; 2002; 4(5):R9. PubMed ID: 12223126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of MAGI2-AS3 in malignant and non-malignant disorders.
    Taheri M; Askari A; Hussen BM; Ghafouri-Fard S; Rashnoo F
    Pathol Res Pract; 2023 Jun; 246():154530. PubMed ID: 37196468
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of the apoptosis-inducing ligands FasL and TRAIL in malignant and benign human breast tumors.
    Herrnring C; Reimer T; Jeschke U; Makovitzky J; Krüger K; Gerber B; Kabelitz D; Friese K
    Histochem Cell Biol; 2000 Mar; 113(3):189-94. PubMed ID: 10817673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LncRNA MAGI2-AS3 is involved in cervical squamous cell carcinoma development through CDK6 up-regulation.
    Liu Q; Liu S; Wang X; Zhang J; Liu K
    Infect Agent Cancer; 2019; 14():37. PubMed ID: 31832086
    [TBL] [Abstract][Full Text] [Related]  

  • 45. β-elemene induces caspase-dependent apoptosis in human glioma cells in vitro through the upregulation of Bax and Fas/ FasL and downregulation of Bcl-2.
    Li CL; Chang L; Guo L; Zhao D; Liu HB; Wang QS; Zhang P; Du WZ; Liu X; Zhang HT; Liu Y; Zhang Y; Xie JH; Ming JG; Cui YQ; Sun Y; Zhang ZR; Jiang CL
    Asian Pac J Cancer Prev; 2014; 15(23):10407-12. PubMed ID: 25556484
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LncRNA MAGI2-AS3 Affects Cell Invasion and Migration of Cervical Squamous Cell Carcinoma (CSCC) via Sponging miRNA-233/EPB41L3 Axis.
    Hou A; Zhang Y; Fan Y; Zheng Y; Zhou X; Liu H
    Cancer Manag Res; 2020; 12():4209-4216. PubMed ID: 32581592
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long non-coding RNA RUNX1-IT1 plays a tumour-suppressive role in colorectal cancer by inhibiting cell proliferation and migration.
    Shi J; Zhong X; Song Y; Wu Z; Gao P; Zhao J; Sun J; Wang J; Liu J; Wang Z
    Cell Biochem Funct; 2019 Jan; 37(1):11-20. PubMed ID: 30499136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. lncRNA MAGI2-AS3 overexpression had antitumor effect on Hepatic cancer via miRNA-23a-3p/PTEN axis.
    Liu F; Deng W; Wan Z; Xu D; Chen J; Yang X; Xu J
    Food Sci Nutr; 2021 May; 9(5):2517-2530. PubMed ID: 34026068
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
    J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MAGI2-AS3 restrains proliferation, glycolysis, and triggers apoptosis in acute lymphoblastic leukemia via regulating miR-452-5p/FOXN3 pathway.
    Chen XG; Dou BH; An JD; Feng S; Liu N; Sheng GY
    Iran J Basic Med Sci; 2022 Jan; 25(1):46-52. PubMed ID: 35656441
    [TBL] [Abstract][Full Text] [Related]  

  • 51. lncRNA MAGI2-AS3 Exerts Antioncogenic Roles in Hepatocellular Carcinoma via Regulating the miR-519c-3p/TXNIP Axis.
    Wei H; Tang Q; Wang A; Zhang Y; Qin Z; Li W; Xu Z; Wang J; Pu J
    J Oncol; 2021; 2021():5547345. PubMed ID: 34484334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The diplotype Fas -1377A/-670G as a genetic marker to predict a lower risk of breast cancer in Chinese women.
    Xu Y; Deng Q; He B; Pan Y; Li R; Gao T; Sun H; Song G; Wang S; Cho WC
    Tumour Biol; 2014 Sep; 35(9):9147-61. PubMed ID: 24916571
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells.
    Lee TB; Min YD; Lim SC; Kim KJ; Jeon HJ; Choi SM; Choi CH
    J Gastroenterol Hepatol; 2002 Jan; 17(1):32-8. PubMed ID: 11895550
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional polymorphisms of FAS and FASL gene and risk of breast cancer - pilot study of 134 cases.
    Hashemi M; Fazaeli A; Ghavami S; Eskandari-Nasab E; Arbabi F; Mashhadi MA; Taheri M; Chaabane W; Jain MV; Łos MJ
    PLoS One; 2013; 8(1):e53075. PubMed ID: 23326385
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Downregulation of the long non-coding RNA TUG1 is associated with cell proliferation, migration, and invasion in breast cancer.
    Fan S; Yang Z; Ke Z; Huang K; Liu N; Fang X; Wang K
    Biomed Pharmacother; 2017 Nov; 95():1636-1643. PubMed ID: 28950664
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of apoptosis in breast cancer cells in vitro by Fas ligand reverse signaling.
    Kolben T; Jeschke U; Reimer T; Karsten N; Schmoeckel E; Semmlinger A; Mahner S; Harbeck N; Kolben TM
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):249-256. PubMed ID: 29185091
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long noncoding RNA Saf and splicing factor 45 increase soluble Fas and resistance to apoptosis.
    Villamizar O; Chambers CB; Riberdy JM; Persons DA; Wilber A
    Oncotarget; 2016 Mar; 7(12):13810-26. PubMed ID: 26885613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells.
    Ragnarsson GB; Mikaelsdottir EK; Vidarsson H; Jónasson JG; Olafsdóttir K; Kristjánsdóttir K; Kjartansson J; Ogmundsdóttir HM; Rafnar T
    Br J Cancer; 2000 Dec; 83(12):1715-21. PubMed ID: 11104571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of lncRNA PANDAR reduces cell proliferation, cell invasion and suppresses EMT pathway in breast cancer.
    Li Y; Su X; Pan H
    Cancer Biomark; 2019; 25(2):185-192. PubMed ID: 31104011
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comprehensive analysis of the FOXA1-related ceRNA network and identification of the MAGI2-AS3/DUSP2 axis as a prognostic biomarker in prostate cancer.
    Yang G; Chen X; Quan Z; Liu M; Guo Y; Tang Y; Peng L; Wang L; Wu Y; Wu X; Liu J; Zheng Y
    Front Oncol; 2023; 13():1048521. PubMed ID: 36998469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.